Legend Biotech Corp

Related Filers (13)

Other (174)

6-K
Tuesday, 1/23/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/23/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/9/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Wednesday, 12/27/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 12/22/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 12/22/2023
Filing for proposed sale of securities under Rule 144
6-K
Thursday, 12/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
6-K
Tuesday, 12/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 10/17/2023
Filing for proposed sale of securities under Rule 144
144/A
Tuesday, 10/17/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 10/16/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 9/27/2023
Filing for proposed sale of securities under Rule 144
6-K
Monday, 9/25/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Friday, 9/22/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 9/22/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 9/18/2023
Filing for proposed sale of securities under Rule 144
CORRESP
Friday, 9/8/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Monday, 8/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Wednesday, 8/23/2023
Filing for proposed sale of securities under Rule 144
6-K
Monday, 8/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Monday, 6/26/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 6/22/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 6/22/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 6/7/2023
Filing for proposed sale of securities under Rule 144
6-K
Tuesday, 6/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 6/6/2023
Filing for proposed sale of securities under Rule 144
6-K
Monday, 6/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Monday, 6/5/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 6/2/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 6/1/2023
Filing for proposed sale of securities under Rule 144
F-3ASR
Friday, 5/26/2023
Automatic shelf registration statement of securities of well-known seasoned issuers
6-K
Thursday, 5/25/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
D
Friday, 4/28/2023
Exempt (Private) Offering
144
Friday, 4/21/2023
Filing for proposed sale of securities under Rule 144
6-K
Friday, 4/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Wednesday, 4/19/2023
Filing for proposed sale of securities under Rule 144
6-K
Wednesday, 4/19/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Wednesday, 4/5/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 4/5/2023
Filing for proposed sale of securities under Rule 144
6-K
Monday, 4/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Monday, 4/3/2023
Filing for proposed sale of securities under Rule 144
20-F
Thursday, 3/30/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Friday, 2/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F/A
Friday, 2/17/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 1/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/20/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/18/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Tuesday, 10/11/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Monday, 10/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Friday, 9/30/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 9/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/5/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/6/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/26/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/18/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/9/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/9/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/6/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 3/31/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 3/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/18/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Show More

Ownership (17)

SC 13G
Wednesday, 2/14/2024
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
GenScript Biotech Corp: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
HILLHOUSE INVESTMENT MANAGEMENT, LTD.: Major Shareholders
SC 13G/A
Friday, 2/9/2024
FMR LLC: Major Shareholders
SC 13G
Monday, 1/29/2024
BlackRock Inc.: Major Shareholders
SC 13G/A
Wednesday, 5/10/2023
FMR LLC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Zhang Fangliang: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
HILLHOUSE INVESTMENT MANAGEMENT, LTD.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
GenScript Biotech Corp: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
AquaPoint L.P.: Major Shareholders
SC 13G
Thursday, 2/9/2023
FMR LLC: Major Shareholders
SC 13G/A
Friday, 3/11/2022
GenScript Biotech Corp: Major Shareholders
SC 13G/A
Monday, 2/14/2022
HILLHOUSE INVESTMENT MANAGEMENT, LTD.: Major Shareholders
SC 13G
Monday, 7/12/2021
HILLHOUSE INVESTMENT MANAGEMENT, LTD.: Major Shareholders
SC 13G
Tuesday, 2/16/2021
GenScript Biotech Corp: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Zhang Fangliang: Major Shareholders
SC 13G
Tuesday, 2/16/2021
AquaPoint L.P.: Major Shareholders
Show More

Prospectus (15)

424B5
Monday, 5/8/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 7/27/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 7/25/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 12/17/2021
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Thursday, 12/16/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Tuesday, 12/14/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Wednesday, 7/14/2021
Prospectus filed pursuant to Rule 424(b)(3)
S-8 POS
Friday, 9/4/2020
Post-effective amendment to a S-8 registration statement
S-8
Friday, 6/26/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Monday, 6/8/2020
Prospectus filed pursuant to Rule 424(b)(4)
DRSLTR
Friday, 5/8/2020
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 5/8/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Monday, 4/20/2020
Correspondence Related to Draft Registration Statement
DRS/A
Monday, 4/20/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Monday, 3/9/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Show More